Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1995 February; 88(2): 111P–112P.
PMCID: PMC1295113

Two macroprolactinomas presenting with neurological signs.


Macroprolactinomas commonly cause pressure effects on immediate parasellar structures, in particular on the optic chiasm to cause visual field defects. Pressure on more distant brain structures is rarely reported. We describe two massive prolactinomas presenting with neurological signs, including signs of hemiparesis which, to our knowledge, has not been reported previously.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (678K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wass JA, Williams J, Charlesworth M, Kingsley DP, Halliday AM, Doniach I, Rees LH, McDonald WI, Besser GM. Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) 1982 Jun 26;284(6333):1908–1911. [PMC free article] [PubMed]
  • Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985 Apr;60(4):698–705. [PubMed]
  • Bevan JS, Webster J, Burke CW, Scanlon MF. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev. 1992 May;13(2):220–240. [PubMed]
  • Serri O, Rasio E, Beauregard H, Hardy J, Somma M. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med. 1983 Aug 4;309(5):280–283. [PubMed]
  • Faria MA, Jr, Tindall GT. Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas. J Neurosurg. 1982 Jan;56(1):33–43. [PubMed]
  • Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol (Oxf) 1991 Nov;35(5):379–397. [PubMed]
  • Tsagarakis S, Grossman A, Plowman PN, Jones AE, Touzel R, Rees LH, Wass JA, Besser GM. Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up. Clin Endocrinol (Oxf) 1991 May;34(5):399–406. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press